Strategic Blueprint LLC cut its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 39.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,647 shares of the company's stock after selling 19,898 shares during the quarter. Strategic Blueprint LLC's holdings in Procter & Gamble were worth $4,392,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Maseco LLP purchased a new stake in shares of Procter & Gamble in the fourth quarter worth about $28,000. Saranac Partners Ltd purchased a new stake in shares of Procter & Gamble in the third quarter worth about $30,000. Corundum Trust Company INC purchased a new stake in shares of Procter & Gamble in the third quarter worth about $32,000. Caitlin John LLC purchased a new stake in shares of Procter & Gamble in the third quarter worth about $34,000. Finally, Marquette Asset Management LLC purchased a new stake in shares of Procter & Gamble in the third quarter worth about $37,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
Procter & Gamble Trading Up 0.2%
NYSE:PG opened at $148.43 on Tuesday. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44. The business's 50 day moving average is $150.08 and its two-hundred day moving average is $148.64. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $170.99. The company has a market cap of $344.95 billion, a PE ratio of 21.70, a P/E/G ratio of 5.72 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, topping analysts' consensus estimates of $1.56 by $0.03. Procter & Gamble had a return on equity of 31.88% and a net margin of 19.16%.The company had revenue of $21.24 billion for the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter last year, the business posted $1.54 EPS. Procter & Gamble's quarterly revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts predict that Procter & Gamble Company will post 6.95 EPS for the current year.
Procter & Gamble Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be issued a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a yield of 2.9%. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. Procter & Gamble's dividend payout ratio (DPR) is 63.60%.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
Analyst Upgrades and Downgrades
PG has been the subject of a number of analyst reports. UBS Group increased their price target on Procter & Gamble from $166.00 to $172.00 and gave the company a "buy" rating in a report on Monday. Raymond James Financial reduced their price target on Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating for the company in a report on Tuesday, April 14th. The Goldman Sachs Group reduced their price target on Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a report on Wednesday, April 8th. Bank of America reduced their price target on Procter & Gamble from $171.00 to $167.00 and set a "buy" rating for the company in a report on Friday, April 10th. Finally, Morgan Stanley reduced their price target on Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating for the company in a report on Wednesday, April 22nd. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of "Moderate Buy" and a consensus price target of $161.06.
Get Our Latest Analysis on Procter & Gamble
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 36,093 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the transaction, the chief executive officer owned 34,994 shares of the company's stock, valued at $5,680,576.02. This trade represents a 50.77% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction that occurred on Friday, February 13th. The stock was sold at an average price of $162.28, for a total value of $2,461,625.32. Following the transaction, the insider directly owned 44,735 shares in the company, valued at approximately $7,259,595.80. This represents a 25.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 252,715 shares of company stock worth $40,966,904 over the last quarter. 0.20% of the stock is owned by corporate insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.